Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01879176 | Cytokine Removal in Cardiopulmonary Bypass Patients | PHASE3 | COMPLETED | 46 | — | — | Aug 1, 2013 | May 1, 2015 | Feb 23, 2017 | 1 | Austria |
| Arm | Type | Description |
|---|---|---|
| CytoSorb | EXPERIMENTAL | For the intervention group, the CytoSorb filter will be installed on the CPB machine in a parallel circuit to the body circulation. The flow through the filter will be driven by a roller pump with 200ml.min-1 . |
| Control | NO_INTERVENTION | No filter will be installed on the CPB machine. |
| Name | Type | Description |
|---|---|---|
| CytoSorb | DEVICE | - |
Inclusion Criteria: * elective cardiac surgical intervention with an expected CBP duration \>120 minutes Exclusion Criteria: * Emergency procedures * Heart transplantation * Elective left ventricular assist device (LVAD) implantation * Pulmonary thromendarterectomy * Declined informed consent * S...